Long Covid-19: Proposed Primary Care Clinical Guidelines for Diagnosis and Disease Management.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
20 04 2021
Historique:
received: 19 02 2021
revised: 02 04 2021
accepted: 16 04 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 5 5 2021
Statut: epublish

Résumé

Long COVID-19 may be defined as patients who, four weeks after the diagnosis of SARS-Cov-2 infection, continue to have signs and symptoms not explainable by other causes. The estimated frequency is around 10% and signs and symptoms may last for months. The main long-term manifestations observed in other coronaviruses (Severe Acute Respiratory Syndrome (SARS), Middle East respiratory syndrome (MERS)) are very similar to and have clear clinical parallels with SARS-CoV-2: mainly respiratory, musculoskeletal, and neuropsychiatric. The growing number of patients worldwide will have an impact on health systems. Therefore, the main objective of these clinical practice guidelines is to identify patients with signs and symptoms of long COVID-19 in primary care through a protocolized diagnostic process that studies possible etiologies and establishes an accurate differential diagnosis. The guidelines have been developed pragmatically by compiling the few studies published so far on long COVID-19, editorials and expert opinions, press releases, and the authors' clinical experience. Patients with long COVID-19 should be managed using structured primary care visits based on the time from diagnosis of SARS-CoV-2 infection. Based on the current limited evidence, disease management of long COVID-19 signs and symptoms will require a holistic, longitudinal follow up in primary care, multidisciplinary rehabilitation services, and the empowerment of affected patient groups.

Identifiants

pubmed: 33923972
pii: ijerph18084350
doi: 10.3390/ijerph18084350
pmc: PMC8073248
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Nat Rev Dis Primers. 2020 Jul 15;6(1):60
pubmed: 32669623
J Med Virol. 2020 Jul;92(7):891-902
pubmed: 32314805
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
BMJ. 2020 Aug 13;370:m3218
pubmed: 32816748
Expert Rev Gastroenterol Hepatol. 2021 Jan;15(1):41-50
pubmed: 32955375
Acad Radiol. 2021 Jan;28(1):28-35
pubmed: 33132007
Clin Infect Dis. 2020 Nov 30;:
pubmed: 33252665
J Intern Med. 2021 Jan 5;:
pubmed: 33403772
J Intern Med. 2020 Sep;288(3):335-344
pubmed: 32352202
Clin Microbiol Infect. 2020 Jun;26(6):767-772
pubmed: 32304745
Blood. 2020 Sep 10;136(11):1347-1350
pubmed: 32746455
Int J Infect Dis. 2020 May;94:81-87
pubmed: 32205284
BMJ. 2020 Aug 11;370:m3026
pubmed: 32784198
Med Clin (Barc). 2021 Jan 8;156(1):35-36
pubmed: 33077167
J Am Coll Radiol. 2020 Jun;17(6):701-709
pubmed: 32283052
PLoS One. 2020 Nov 9;15(11):e0240784
pubmed: 33166287
Intensive Care Med. 2020 Jul;46(7):1445-1448
pubmed: 32367169
J Med Virol. 2021 Feb;93(2):1013-1022
pubmed: 32729939
Thorax. 2020 Nov 10;:
pubmed: 33172844
JAMA Cardiol. 2020 Nov 1;5(11):1265-1273
pubmed: 32730619
Int J Infect Dis. 2020 Nov;100:507-512
pubmed: 32950734
Clin Microbiol Infect. 2021 Feb;27(2):258-263
pubmed: 33031948
Respir Med. 2020 Dec 31;177:106292
pubmed: 33440299
Eur Respir J. 2020 Aug 6;56(2):
pubmed: 32554533
Am J Emerg Med. 2012 Feb;30(2):317-24
pubmed: 21277143
Lancet. 2021 Jan 16;397(10270):220-232
pubmed: 33428867
Dig Liver Dis. 2020 Oct;52(10):1076-1079
pubmed: 32507692
Nat Med. 2021 Jan;27(1):28-33
pubmed: 33442016
Blood. 2020 Sep 10;136(11):1342-1346
pubmed: 32766883
Blood. 2020 Jun 4;135(23):2033-2040
pubmed: 32339221
EClinicalMedicine. 2020 Aug;25:100463
pubmed: 32838236
Lancet. 2020 Aug 29;396(10251):598-599
pubmed: 32798450
JACC Cardiovasc Imaging. 2021 Mar;14(3):541-555
pubmed: 33223496
Dan Med J. 2020 Aug 1;67(8):
pubmed: 32741438
Clin Infect Dis. 2020 Nov 21;:
pubmed: 33220049
Nat Rev Neurol. 2021 Feb;17(2):63
pubmed: 33398125
JAMA. 2020 Aug 11;324(6):603-605
pubmed: 32644129
J Intern Med. 2020 Oct;288(4):469-476
pubmed: 32498135
Neurology. 2020 Aug 25;95(8):e1060-e1070
pubmed: 32482845
Sci Adv. 2021 Mar 19;7(12):
pubmed: 33741586
BMJ. 2020 Dec 23;371:m4938
pubmed: 33361141
Laryngoscope. 2020 Nov;130(11):2667-2673
pubmed: 32617990
J Clin Med. 2020 Oct 29;9(11):
pubmed: 33137919
Otolaryngol Head Neck Surg. 2021 Mar;164(3):512-518
pubmed: 32867582
J Clin Med. 2020 Jun 04;9(6):
pubmed: 32512688
Laryngoscope. 2020 Nov;130(11):2680-2685
pubmed: 32794209
Respir Med. 2020 Nov - Dec;174:106197
pubmed: 33120193
J Infect. 2020 Dec;81(6):e4-e6
pubmed: 32853602
Lancet Neurol. 2020 Nov;19(11):919-929
pubmed: 33031735
Cephalalgia. 2020 Nov;40(13):1410-1421
pubmed: 33146036
Eur Respir J. 2020 May 14;55(5):
pubmed: 32217650
Lancet. 2021 Feb 6;397(10273):455-457
pubmed: 33357467
Nat Med. 2020 Dec;26(12):1829-1834
pubmed: 33020651
BMJ. 2020 Sep 7;370:m3489
pubmed: 32895219
N Engl J Med. 2020 Nov 5;383(19):1813-1826
pubmed: 32445440
JAMA Cardiol. 2020 Nov 1;5(11):1216-1217
pubmed: 32730614
BMJ. 2020 May 29;369:m1996
pubmed: 32471884
BMC Neurol. 2011 Mar 24;11:37
pubmed: 21435231
PLoS One. 2020 Aug 21;15(8):e0237960
pubmed: 32822413
Intern Emerg Med. 2020 Aug;15(5):813-817
pubmed: 32474850
Gastroenterology. 2020 May;158(6):1831-1833.e3
pubmed: 32142773
Viruses. 2020 Dec 03;12(12):
pubmed: 33287245
MMWR Morb Mortal Wkly Rep. 2020 Jul 31;69(30):993-998
pubmed: 32730238
Eur Respir J. 2020 Jun 18;55(6):
pubmed: 32381497

Auteurs

Antoni Sisó-Almirall (A)

Permanent Board of the Catalan Society of Family and Community Medicine (CAMFiC), 08009 Barcelona, Spain.
Primary Care Centre Les Corts, Consorci d'Atenció Primària de Salut Barcelona Esquerra (CAPSBE), 08028 Barcelona, Spain.
Primary Healthcare Transversal Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.

Pilar Brito-Zerón (P)

Laboratory of Autoimmune Diseases Josep Font, IDIBAPS-CELLEX, 08036 Barcelona, Spain.
Autoimmune Diseases Unit, Department of Medicine, Hospital CIMA-Sanitas, 08034 Barcelona, Spain.
Department of Autoimmune Diseases, ICMiD, Hospital Clínic, 08036 Barcelona, Spain.

Laura Conangla Ferrín (L)

Permanent Board of the Catalan Society of Family and Community Medicine (CAMFiC), 08009 Barcelona, Spain.

Belchin Kostov (B)

Primary Care Centre Les Corts, Consorci d'Atenció Primària de Salut Barcelona Esquerra (CAPSBE), 08028 Barcelona, Spain.
Primary Healthcare Transversal Research Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain.
Department of Statistics and Operations Research, Universitat Politècnica de Catalunya (UPC), 08034 Barcelona, Spain.

Anna Moragas Moreno (A)

Jaume I Health Centre, Institut Català de la Salut, Universitat Rovira i Virgili, 43005 Tarragona, Spain.

Jordi Mestres (J)

Permanent Board of the Catalan Society of Family and Community Medicine (CAMFiC), 08009 Barcelona, Spain.

Jaume Sellarès (J)

College of Catalan Physicians, 08017 Barcelona, Spain.

Gisela Galindo (G)

Permanent Board of the Spanish Society of Family and Community Medicine (semFYC), 08009 Barcelona, Spain.

Ramon Morera (R)

Board of Spanish Society of Managers of Primary Care (SEDAP), 28026 Madrid, Spain.

Josep Basora (J)

IDIAP Jordi Gol, 08007 Barcelona, Spain.

Antoni Trilla (A)

Faculty of Medicine and Health Sciences, University of Barcelona, 08036 Barcelona, Spain.

Manuel Ramos-Casals (M)

Laboratory of Autoimmune Diseases Josep Font, IDIBAPS-CELLEX, 08036 Barcelona, Spain.
Department of Autoimmune Diseases, ICMiD, Hospital Clínic, 08036 Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH